CNMD CONMED PE ratio, current and historical analysis
As of Apr 1, 2025, the CONMED stock's P/E ratio is 13.85. This takes into account the latest EPS of $4.29 and stock price of $59.4. The PE ratio has decreased by 34% from its last 4 quarters average of 21.0.
CNMD PE ratio history
The PE ratio of CONMED has averaged 249.42 over the last ten years. The current price-to-earnings ratio of 13.85 is 94% less than the historical average. Analyzing the last ten years, CNMD's PE ratio reached its highest point in the Sep 2020 quarter at 3,933.5, when the price was $78.67 and the EPS was $0.02. The lowest point was recorded in the Dec 2024 quarter, when it reached 15.95 with a price of $68.44 and an EPS of $4.29.
CONMED PE ratio by year
Maximum annual increase: 3,332.29% in 2011
Maximum annual decrease: -97.72% in 2012
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 15.95 | -69.42% | $68.44 | $4.29 |
| 2023 | 52.15 | N/A | $109.51 | $2.1 |
| 2022 | N/A | N/A | $88.64 | -$2.68 |
| 2021 | 66.24 | -80.48% | $141.76 | $2.14 |
| 2020 | 339.39 | 206.53% | $112 | $0.33 |
| 2019 | 110.72 | 150.05% | $111.83 | $1.01 |
| 2018 | 44.28 | 72.9% | $64.2 | $1.45 |
| 2017 | 25.61 | -69.27% | $50.97 | $1.99 |
| 2016 | 83.34 | 108.09% | $44.17 | $0.53 |
| 2015 | 40.05 | 4.22% | $44.05 | $1.1 |
| 2014 | 38.43 | 17.56% | $44.96 | $1.17 |
| 2013 | 32.69 | 67.21% | $42.5 | $1.3 |
| 2012 | 19.55 | -97.72% | $27.95 | $1.43 |
| 2011 | 855.67 | 3,332.29% | $25.67 | $0.03 |
| 2010 | 24.93 | -54.08% | $26.43 | $1.06 |
CONMED PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 15.95 | -5.06% | $68.44 | $4.29 |
| Sep 2024 | 16.8 | -22.22% | $71.92 | $4.28 |
| Jun 2024 | 21.6 | -27.44% | $69.32 | $3.21 |
| Mar 2024 | 29.77 | -42.91% | $80.08 | $2.69 |
| Dec 2023 | 52.15 | 0.33% | $109.51 | $2.1 |
| Sep 2023 | 51.98 | 12.07% | $100.85 | $1.94 |
| Jun 2023 | 46.38 | N/A | $135.89 | $2.93 |
| Mar 2023 | N/A | N/A | $103.86 | -$3.17 |
| Dec 2022 | N/A | N/A | $88.64 | -$2.68 |
| Sep 2022 | N/A | N/A | $80.17 | -$2.8 |
| Jun 2022 | N/A | N/A | $95.76 | -$3.8 |
| Mar 2022 | 64.31 | -2.91% | $148.55 | $2.31 |
| Dec 2021 | 66.24 | 8.86% | $141.76 | $2.14 |
| Sep 2021 | 60.85 | -16.76% | $130.83 | $2.15 |
| Jun 2021 | 73.1 | -74.25% | $137.43 | $1.88 |
CNMD average PE ratio chart
CNMD's current PE ratio is under its 3, 5 and 10-year averages.
CNMD PE vs peers
CNMD's PE ratio is below its peer stocks JNJ and BSX. CONMED's current PE ratio of 13.85 is less than the average of its peers, which is 54.99.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNMD CONMED Corp | 13.85 | $1.84B |
| JNJ Johnson & Johnson | 26.24 | $368.97B |
| MDT Medtronic plc | 26.73 | $113.49B |
| SYK Stryker Corp | 47.49 | $142.44B |
| BSX Boston Scientific Corp | 80.35 | $149.41B |
| TFX Teleflex Inc | 94.16 | $6.51B |
| IART Integra Lifesciences Holdings Corp | N/A | $1.67B |
Frequently asked questions
What is CONMED's PE ratio?
CNMD's price to earnings ratio is 13.85 as of Apr 1, 2025.
What is the 3-year average PE ratio for CONMED (CNMD)?
As an average over the last 3 years, CNMD stock has a PE ratio of 33.52.
What is the 5-year average PE ratio for CONMED (CNMD)?
As an average over the last 5 years, CNMD stock has a PE ratio of 497.04.
What is the highest PE ratio for CNMD?
Over the last ten years, the Sep 2020 quarter recorded the highest quarterly PE ratio at 3,933.5.
How does the current PE ratio for CNMD compare to its historical average?
CNMD's price to earnings ratio is currently 94% below its 10-year historical average.
How is CNMD's PE ratio calculated (CONMED PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Apr 1, 2025), CONMED's share price is $59.4. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $4.29. Therefore, CONMED's price to earnings ratio for today is 13.85. PE RATIO(13.85) = STOCK PRICE($59.4) / TTM EPS($4.29)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.